Judicial Panel on Multidistrict Litigation entered an order centralizing GLP-1 NAION lawsuits filed or pending in federal court for pre-trial proceedings in an MDL, styled as In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAS) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation, MDL Case No
Without the DAC molecule attached, CJC-1295 has a half-life of approximately 30 minutes
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not a pure GLP-1 agonist
Multi-peptide stacks combining several compounds may cost more than single peptides
Inhibiting ACSL4 disrupts PUFA metabolism by inhibiting the formation of AA/AdA-CoA from AA/AdA, thus limiting the integration of PUFAs into membrane phospholipids [19]
Solutions prepared in organic vehicles (DMSO, PEG, oils) are best regarded as short-lived and non-sterile